APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Contraceptives

Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.

Selected research

Market Analysis & Forecast

Global Contraceptives Market Analysis and Forecast 2026-2032

Report ID 173980770226 December 2025205 pages

Choose your research edition.

Industry ResearchContraceptives Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptives Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Contraceptives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptives Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptives Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.

Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.

The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.

Read the full market overview

This report presents an overview of global market for Contraceptives, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Contraceptives, also provides the sales of main regions and countries. Of the upcoming market potential for Contraceptives, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Contraceptives sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Contraceptives market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Contraceptives sales, projected growth trends, production technology, application and end-user industry.

Contraceptives Segment by Company

Bayer AG

Pfizer, Inc

Teva Pharmaceutical Industries Ltd

Merck & Co., Inc

Actavis, Inc.

Johnson & Johnson

Gedeon Richter

Novo Nordisk A/S

ZiZhu

Baijingyu

Huazhong

Sine

Reckitt

AbbVie

Church & Dwight

The Cooper Companies

TherapeuticsMD

Afaxys

Mithra Pharmaceuticals

Contraceptives Segment by Type

Pills

Injectable

Condoms

Vaginal Rings

IUDs

Subdermal Implants

Others

Contraceptives Segment by End User

15–24 years

25–34 years

35–44 years

Above 44 years

Contraceptives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Contraceptives in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Contraceptives manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contraceptives sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Contraceptives Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pills Major Manufacturers Table 3. Injectable Major Manufacturers Table 4. Condoms Major Manufacturers Table 5. Vaginal Rings Major Manufacturers Table 6. IUDs Major Manufacturers Table 7. Subdermal Implants Major Manufacturers Table 8. Others Major Manufacturers Table 9. Global Contraceptives Market Size Growth Rate by End User (US$ Million), 2021 VS 2025 VS 2032 Table 10. 15–24 years Major Manufacturers Table 11. 25–34 years Major Manufacturers Table 12. 35–44 years Major Manufacturers Table 13. Above 44 years Major Manufacturers Table 14. Contraceptives Industry Trends Table 15. Contraceptives Industry Drivers Table 16. Contraceptives Industry Opportunities and Challenges Table 17. Contraceptives Industry Restraints Table 18. Global Contraceptives Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Contraceptives Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Contraceptives Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Contraceptives Revenue Market Share by Region (2021-2026) Table 22. Global Contraceptives Revenue Market Share by Region (2027-2032) Table 23. Global Contraceptives Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 24. Global Contraceptives Sales by Region (2021-2026) & (M Units) Table 25. Global Contraceptives Sales by Region (2027-2032) & (M Units) Table 26. Global Contraceptives Sales Market Share by Region (2021-2026) Table 27. Global Contraceptives Sales Market Share by Region (2027-2032) Table 28. Global Contraceptives Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Contraceptives Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Contraceptives Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Contraceptives Sales Market Share by Manufacturers (2021-2026) Table 32. Global Contraceptives Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 33. Global Contraceptives Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Contraceptives Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Contraceptives Manufacturers, Product Type & Application Table 36. Global Contraceptives Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Contraceptives by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Contraceptives Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Contraceptives Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Contraceptives Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Contraceptives Revenue Market Share by Type (2021-2026) Table 43. Global Contraceptives Revenue Market Share by Type (2027-2032) Table 44. Global Contraceptives Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 45. Global Contraceptives Sales by Type (2021-2026) & (M Units) Table 46. Global Contraceptives Sales by Type (2027-2032) & (M Units) Table 47. Global Contraceptives Sales Market Share by Type (2021-2026) Table 48. Global Contraceptives Sales Market Share by Type (2027-2032) Table 49. Global Contraceptives Price by Type (2021-2026) & (USD/Unit) Table 50. Global Contraceptives Price by Type (2027-2032) & (USD/Unit) Table 51. Global Contraceptives Revenue by End User 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Contraceptives Revenue by End User (2021-2026) & (US$ Million) Table 53. Global Contraceptives Revenue by End User (2027-2032) & (US$ Million) Table 54. Global Contraceptives Revenue Market Share by End User (2021-2026) Table 55. Global Contraceptives Revenue Market Share by End User (2027-2032) Table 56. Global Contraceptives Sales by End User 2021 VS 2025 VS 2032 (M Units) Table 57. Global Contraceptives Sales by End User (2021-2026) & (M Units) Table 58. Global Contraceptives Sales by End User (2027-2032) & (M Units) Table 59. Global Contraceptives Sales Market Share by End User (2021-2026) Table 60. Global Contraceptives Sales Market Share by End User (2027-2032) Table 61. Global Contraceptives Price by End User (2021-2026) & (USD/Unit) Table 62. Global Contraceptives Price by End User (2027-2032) & (USD/Unit) Table 63. Bayer AG Company Information Table 64. Bayer AG Business Overview Table 65. Bayer AG Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Bayer AG Contraceptives Product Portfolio Table 67. Bayer AG Recent Development Table 68. Pfizer, Inc Company Information Table 69. Pfizer, Inc Business Overview Table 70. Pfizer, Inc Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Pfizer, Inc Contraceptives Product Portfolio Table 72. Pfizer, Inc Recent Development Table 73. Teva Pharmaceutical Industries Ltd Company Information Table 74. Teva Pharmaceutical Industries Ltd Business Overview Table 75. Teva Pharmaceutical Industries Ltd Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio Table 77. Teva Pharmaceutical Industries Ltd Recent Development Table 78. Merck & Co., Inc Company Information Table 79. Merck & Co., Inc Business Overview Table 80. Merck & Co., Inc Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Merck & Co., Inc Contraceptives Product Portfolio Table 82. Merck & Co., Inc Recent Development Table 83. Actavis, Inc. Company Information Table 84. Actavis, Inc. Business Overview Table 85. Actavis, Inc. Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Actavis, Inc. Contraceptives Product Portfolio Table 87. Actavis, Inc. Recent Development Table 88. Johnson & Johnson Company Information Table 89. Johnson & Johnson Business Overview Table 90. Johnson & Johnson Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Johnson & Johnson Contraceptives Product Portfolio Table 92. Johnson & Johnson Recent Development Table 93. Gedeon Richter Company Information Table 94. Gedeon Richter Business Overview Table 95. Gedeon Richter Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Gedeon Richter Contraceptives Product Portfolio Table 97. Gedeon Richter Recent Development Table 98. Novo Nordisk A/S Company Information Table 99. Novo Nordisk A/S Business Overview Table 100. Novo Nordisk A/S Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Novo Nordisk A/S Contraceptives Product Portfolio Table 102. Novo Nordisk A/S Recent Development Table 103. ZiZhu Company Information Table 104. ZiZhu Business Overview Table 105. ZiZhu Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. ZiZhu Contraceptives Product Portfolio Table 107. ZiZhu Recent Development Table 108. Baijingyu Company Information Table 109. Baijingyu Business Overview Table 110. Baijingyu Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Baijingyu Contraceptives Product Portfolio Table 112. Baijingyu Recent Development Table 113. Huazhong Company Information Table 114. Huazhong Business Overview Table 115. Huazhong Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Huazhong Contraceptives Product Portfolio Table 117. Huazhong Recent Development Table 118. Sine Company Information Table 119. Sine Business Overview Table 120. Sine Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. Sine Contraceptives Product Portfolio Table 122. Sine Recent Development Table 123. Reckitt Company Information Table 124. Reckitt Business Overview Table 125. Reckitt Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Reckitt Contraceptives Product Portfolio Table 127. Reckitt Recent Development Table 128. AbbVie Company Information Table 129. AbbVie Business Overview Table 130. AbbVie Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. AbbVie Contraceptives Product Portfolio Table 132. AbbVie Recent Development Table 133. Church & Dwight Company Information Table 134. Church & Dwight Business Overview Table 135. Church & Dwight Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 136. Church & Dwight Contraceptives Product Portfolio Table 137. Church & Dwight Recent Development Table 138. The Cooper Companies Company Information Table 139. The Cooper Companies Business Overview Table 140. The Cooper Companies Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 141. The Cooper Companies Contraceptives Product Portfolio Table 142. The Cooper Companies Recent Development Table 143. TherapeuticsMD Company Information Table 144. TherapeuticsMD Business Overview Table 145. TherapeuticsMD Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 146. TherapeuticsMD Contraceptives Product Portfolio Table 147. TherapeuticsMD Recent Development Table 148. Afaxys Company Information Table 149. Afaxys Business Overview Table 150. Afaxys Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 151. Afaxys Contraceptives Product Portfolio Table 152. Afaxys Recent Development Table 153. Mithra Pharmaceuticals Company Information Table 154. Mithra Pharmaceuticals Business Overview Table 155. Mithra Pharmaceuticals Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 156. Mithra Pharmaceuticals Contraceptives Product Portfolio Table 157. Mithra Pharmaceuticals Recent Development Table 158. North America Contraceptives Revenue by Type (2021-2026) & (US$ Million) Table 159. North America Contraceptives Revenue by Type (2027-2032) & (US$ Million) Table 160. North America Contraceptives Sales by Type (2021-2026) & (M Units) Table 161. North America Contraceptives Sales by Type (2027-2032) & (M Units) Table 162. North America Contraceptives Sales Price by Type (2021-2026) & (USD/Unit) Table 163. North America Contraceptives Sales Price by Type (2027-2032) & (USD/Unit) Table 164. North America Contraceptives Revenue by End User (2021-2026) & (US$ Million) Table 165. North America Contraceptives Revenue by End User (2027-2032) & (US$ Million) Table 166. North America Contraceptives Sales by End User (2021-2026) & (M Units) Table 167. North America Contraceptives Sales by End User (2027-2032) & (M Units) Table 168. North America Contraceptives Sales Price by End User (2021-2026) & (USD/Unit) Table 169. North America Contraceptives Sales Price by End User (2027-2032) & (USD/Unit) Table 170. North America Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. North America Contraceptives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. North America Contraceptives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. North America Contraceptives Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 174. North America Contraceptives Sales by Country (2021-2026) & (M Units) Table 175. North America Contraceptives Sales by Country (2027-2032) & (M Units) Table 176. North America Contraceptives Sales Price by Country (2021-2026) & (USD/Unit) Table 177. North America Contraceptives Sales Price by Country (2027-2032) & (USD/Unit) Table 178. United States Contraceptives Revenue (2021-2032) & (US$ Million) Table 179. Canada Contraceptives Revenue (2021-2032) & (US$ Million) Table 180. Mexico Contraceptives Revenue (2021-2032) & (US$ Million) Table 181. Europe Contraceptives Revenue by Type (2021-2026) & (US$ Million) Table 182. Europe Contraceptives Revenue by Type (2027-2032) & (US$ Million) Table 183. Europe Contraceptives Sales by Type (2021-2026) & (M Units) Table 184. Europe Contraceptives Sales by Type (2027-2032) & (M Units) Table 185. Europe Contraceptives Sales Price by Type (2021-2026) & (USD/Unit) Table 186. Europe Contraceptives Sales Price by Type (2027-2032) & (USD/Unit) Table 187. Europe Contraceptives Revenue by End User (2021-2026) & (US$ Million) Table 188. Europe Contraceptives Revenue by End User (2027-2032) & (US$ Million) Table 189. Europe Contraceptives Sales by End User (2021-2026) & (M Units) Table 190. Europe Contraceptives Sales by End User (2027-2032) & (M Units) Table 191. Europe Contraceptives Sales Price by End User (2021-2026) & (USD/Unit) Table 192. Europe Contraceptives Sales Price by End User (2027-2032) & (USD/Unit) Table 193. Europe Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Europe Contraceptives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Europe Contraceptives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Europe Contraceptives Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 197. Europe Contraceptives Sales by Country (2021-2026) & (M Units) Table 198. Europe Contraceptives Sales by Country (2027-2032) & (M Units) Table 199. Europe Contraceptives Sales Price by Country (2021-2026) & (USD/Unit) Table 200. Europe Contraceptives Sales Price by Country (2027-2032) & (USD/Unit) Table 201. Germany Contraceptives Revenue (2021-2032) & (US$ Million) Table 202. France Contraceptives Revenue (2021-2032) & (US$ Million) Table 203. U.K. Contraceptives Revenue (2021-2032) & (US$ Million) Table 204. Italy Contraceptives Revenue (2021-2032) & (US$ Million) Table 205. Russia Contraceptives Revenue (2021-2032) & (US$ Million) Table 206. Spain Contraceptives Revenue (2021-2032) & (US$ Million) Table 207. Netherlands Contraceptives Revenue (2021-2032) & (US$ Million) Table 208. Switzerland Contraceptives Revenue (2021-2032) & (US$ Million) Table 209. Sweden Contraceptives Revenue (2021-2032) & (US$ Million) Table 210. Poland Contraceptives Revenue (2021-2032) & (US$ Million) Table 211. China Contraceptives Revenue by Type (2021-2026) & (US$ Million) Table 212. China Contraceptives Revenue by Type (2027-2032) & (US$ Million) Table 213. China Contraceptives Sales by Type (2021-2026) & (M Units) Table 214. China Contraceptives Sales by Type (2027-2032) & (M Units) Table 215. China Contraceptives Sales Price by Type (2021-2026) & (USD/Unit) Table 216. China Contraceptives Sales Price by Type (2027-2032) & (USD/Unit) Table 217. China Contraceptives Revenue by End User (2021-2026) & (US$ Million) Table 218. China Contraceptives Revenue by End User (2027-2032) & (US$ Million) Table 219. China Contraceptives Sales by End User (2021-2026) & (M Units) Table 220. China Contraceptives Sales by End User (2027-2032) & (M Units) Table 221. China Contraceptives Sales Price by End User (2021-2026) & (USD/Unit) Table 222. China Contraceptives Sales Price by End User (2027-2032) & (USD/Unit) Table 223. Asia Contraceptives Revenue by Type (2021-2026) & (US$ Million) Table 224. Asia Contraceptives Revenue by Type (2027-2032) & (US$ Million) Table 225. Asia Contraceptives Sales by Type (2021-2026) & (M Units) Table 226. Asia Contraceptives Sales by Type (2027-2032) & (M Units) Table 227. Asia Contraceptives Sales Price by Type (2021-2026) & (USD/Unit) Table 228. Asia Contraceptives Sales Price by Type (2027-2032) & (USD/Unit) Table 229. Asia Contraceptives Revenue by End User (2021-2026) & (US$ Million) Table 230. Asia Contraceptives Revenue by End User (2027-2032) & (US$ Million) Table 231. Asia Contraceptives Sales by End User (2021-2026) & (M Units) Table 232. Asia Contraceptives Sales by End User (2027-2032) & (M Units) Table 233. Asia Contraceptives Sales Price by End User (2021-2026) & (USD/Unit) Table 234. Asia Contraceptives Sales Price by End User (2027-2032) & (USD/Unit) Table 235. Asia Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. Asia Contraceptives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. Asia Contraceptives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. Asia Contraceptives Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 239. Asia Contraceptives Sales by Country (2021-2026) & (M Units) Table 240. Asia Contraceptives Sales by Country (2027-2032) & (M Units) Table 241. Asia Contraceptives Sales Price by Country (2021-2026) & (USD/Unit) Table 242. Asia Contraceptives Sales Price by Country (2027-2032) & (USD/Unit) Table 243. Japan Contraceptives Revenue (2021-2032) & (US$ Million) Table 244. South Korea Contraceptives Revenue (2021-2032) & (US$ Million) Table 245. India Contraceptives Revenue (2021-2032) & (US$ Million) Table 246. Australia Contraceptives Revenue (2021-2032) & (US$ Million) Table 247. Taiwan Contraceptives Revenue (2021-2032) & (US$ Million) Table 248. Southeast Asia Contraceptives Revenue (2021-2032) & (US$ Million) Table 249. SAMEA Contraceptives Revenue by Type (2021-2026) & (US$ Million) Table 250. SAMEA Contraceptives Revenue by Type (2027-2032) & (US$ Million) Table 251. SAMEA Contraceptives Sales by Type (2021-2026) & (M Units) Table 252. SAMEA Contraceptives Sales by Type (2027-2032) & (M Units) Table 253. SAMEA Contraceptives Sales Price by Type (2021-2026) & (USD/Unit) Table 254. SAMEA Contraceptives Sales Price by Type (2027-2032) & (USD/Unit) Table 255. SAMEA Contraceptives Revenue by End User (2021-2026) & (US$ Million) Table 256. SAMEA Contraceptives Revenue by End User (2027-2032) & (US$ Million) Table 257. SAMEA Contraceptives Sales by End User (2021-2026) & (M Units) Table 258. SAMEA Contraceptives Sales by End User (2027-2032) & (M Units) Table 259. SAMEA Contraceptives Sales Price by End User (2021-2026) & (USD/Unit) Table 260. SAMEA Contraceptives Sales Price by End User (2027-2032) & (USD/Unit) Table 261. SAMEA Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 262. SAMEA Contraceptives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 263. SAMEA Contraceptives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 264. SAMEA Contraceptives Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 265. SAMEA Contraceptives Sales by Country (2021-2026) & (M Units) Table 266. SAMEA Contraceptives Sales by Country (2027-2032) & (M Units) Table 267. SAMEA Contraceptives Sales Price by Country (2021-2026) & (USD/Unit) Table 268. SAMEA Contraceptives Sales Price by Country (2027-2032) & (USD/Unit) Table 269. Brazil Contraceptives Revenue (2021-2032) & (US$ Million) Table 270. Argentina Contraceptives Revenue (2021-2032) & (US$ Million) Table 271. Chile Contraceptives Revenue (2021-2032) & (US$ Million) Table 272. Colombia Contraceptives Revenue (2021-2032) & (US$ Million) Table 273. Peru Contraceptives Revenue (2021-2032) & (US$ Million) Table 274. Saudi Arabia Contraceptives Revenue (2021-2032) & (US$ Million) Table 275. Israel Contraceptives Revenue (2021-2032) & (US$ Million) Table 276. UAE Contraceptives Revenue (2021-2032) & (US$ Million) Table 277. Turkey Contraceptives Revenue (2021-2032) & (US$ Million) Table 278. Iran Contraceptives Revenue (2021-2032) & (US$ Million) Table 279. Egypt Contraceptives Revenue (2021-2032) & (US$ Million) Table 280. Key Raw Materials Table 281. Raw Materials Key Suppliers Table 282. Contraceptives Distributors List Table 283. Contraceptives Customers List Table 284. Research Programs/Design for This Report Table 285. Authors List of This Report Table 286. Secondary Sources Table 287. Primary Sources List of Figures Figure 1. Contraceptives Image Figure 2. Global Contraceptives Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptives Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pills Image Figure 5. Injectable Image Figure 6. Condoms Image Figure 7. Vaginal Rings Image Figure 8. IUDs Image Figure 9. Subdermal Implants Image Figure 10. Others Image Figure 11. Global Contraceptives Market Size Growth Rate by End User (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Contraceptives Market Size Share 2021 VS 2025 VS 2032 Figure 13. 15–24 years Image Figure 14. 25–34 years Image Figure 15. 35–44 years Image Figure 16. Above 44 years Image Figure 17. Global Contraceptives Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Contraceptives Revenue (2021-2032) & (US$ Million) Figure 19. Global Contraceptives Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Contraceptives Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Contraceptives Revenue Market Share by Region (2021-2032) Figure 22. Global Contraceptives Sales (2021-2032) & (M Units) Figure 23. Global Contraceptives Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 24. Global Contraceptives Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Contraceptives Sales YoY (2021-2032) & (M Units) Figure 26. Europe Contraceptives Sales YoY (2021-2032) & (M Units) Figure 27. China Contraceptives Sales YoY (2021-2032) & (M Units) Figure 28. Asia (Excluding China) Contraceptives Sales YoY (2021-2032) & (M Units) Figure 29. South America, Middle East and Africa Contraceptives Sales YoY (2021-2032) & (M Units) Figure 30. Global Contraceptives Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Contraceptives Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Contraceptives Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Contraceptives Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Contraceptives Revenue Market Share by Type (2021-2032) Figure 36. Global Contraceptives Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 37. Global Contraceptives Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Contraceptives Sales Market Share by Type (2021-2032) Figure 39. Global Contraceptives Revenue by End User (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Contraceptives Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Contraceptives Revenue Market Share by End User (2021-2032) Figure 42. Global Contraceptives Sales by End User (2021 VS 2025 VS 2032) & (M Units) Figure 43. Global Contraceptives Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Contraceptives Sales Market Share by End User (2021-2032) Figure 45. North America Contraceptives Revenue Share by Type (2021-2032) Figure 46. North America Contraceptives Sales Share by Type (2021-2032) Figure 47. North America Contraceptives Revenue Share by End User (2021-2032) Figure 48. North America Contraceptives Sales Share by End User (2021-2032) Figure 49. North America Contraceptives Revenue Share by Country (2021-2032) Figure 50. North America Contraceptives Sales Share by Country (2021-2032) Figure 51. Europe Contraceptives Revenue Share by Type (2021-2032) Figure 52. Europe Contraceptives Sales Share by Type (2021-2032) Figure 53. Europe Contraceptives Revenue Share by End User (2021-2032) Figure 54. Europe Contraceptives Sales Share by End User (2021-2032) Figure 55. Europe Contraceptives Revenue Share by Country (2021-2032) Figure 56. Europe Contraceptives Sales Share by Country (2021-2032) Figure 57. China Contraceptives Revenue Share by Type (2021-2032) Figure 58. China Contraceptives Sales Share by Type (2021-2032) Figure 59. China Contraceptives Revenue Share by End User (2021-2032) Figure 60. China Contraceptives Sales Share by End User (2021-2032) Figure 61. Asia Contraceptives Revenue Share by Type (2021-2032) Figure 62. Asia Contraceptives Sales Share by Type (2021-2032) Figure 63. Asia Contraceptives Revenue Share by End User (2021-2032) Figure 64. Asia Contraceptives Sales Share by End User (2021-2032) Figure 65. Asia Contraceptives Revenue Share by Country (2021-2032) Figure 66. Asia Contraceptives Sales Share by Country (2021-2032) Figure 67. SAMEA Contraceptives Revenue Share by Type (2021-2032) Figure 68. SAMEA Contraceptives Sales Share by Type (2021-2032) Figure 69. SAMEA Contraceptives Revenue Share by End User (2021-2032) Figure 70. SAMEA Contraceptives Sales Share by End User (2021-2032) Figure 71. SAMEA Contraceptives Revenue Share by Country (2021-2032) Figure 72. SAMEA Contraceptives Sales Share by Country (2021-2032) Figure 73. Contraceptives Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Contraceptives Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • Pills
  • Injectable
  • Condoms
  • Vaginal Rings
  • IUDs
  • Subdermal Implants
  • Others
Applications
  • 15–24 years
  • 25–34 years
  • 35–44 years
  • Above 44 years
Companies covered
  • Bayer AG
  • Pfizer, Inc
  • Teva Pharmaceutical Industries Ltd
  • Merck & Co., Inc
  • Actavis, Inc.
  • Johnson & Johnson
  • Gedeon Richter
  • Novo Nordisk A/S
  • ZiZhu
  • Baijingyu
  • Huazhong
  • Sine
  • Reckitt
  • AbbVie
  • Church & Dwight
  • The Cooper Companies
  • TherapeuticsMD
  • Afaxys
  • Mithra Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Contraceptives Market by Type
  3. 1.2.1 Global Contraceptives Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pills
  5. 1.2.3 Injectable
  6. 1.2.4 Condoms
  7. 1.2.5 Vaginal Rings
  8. 1.2.6 IUDs
  9. 1.2.7 Subdermal Implants
  10. 1.2.8 Others
  11. 1.3 Contraceptives Market by End User
  12. 1.3.1 Global Contraceptives Market Size by End User, 2021 VS 2025 VS 2032
  13. 1.3.2 15–24 years
  14. 1.3.3 25–34 years
  15. 1.3.4 35–44 years
  16. 1.3.5 Above 44 years
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Contraceptives Market Dynamics
  1. 2.1 Contraceptives Industry Trends
  2. 2.2 Contraceptives Industry Drivers
  3. 2.3 Contraceptives Industry Opportunities and Challenges
  4. 2.4 Contraceptives Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Contraceptives Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Contraceptives Revenue by Region
  3. 3.2.1 Global Contraceptives Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Contraceptives Revenue by Region (2021-2026)
  5. 3.2.3 Global Contraceptives Revenue by Region (2027-2032)
  6. 3.2.4 Global Contraceptives Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Contraceptives Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Contraceptives Sales by Region
  9. 3.4.1 Global Contraceptives Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Contraceptives Sales by Region (2021-2026)
  11. 3.4.3 Global Contraceptives Sales by Region (2027-2032)
  12. 3.4.4 Global Contraceptives Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Contraceptives Revenue by Manufacturers
  2. 4.1.1 Global Contraceptives Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Contraceptives Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Contraceptives Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Contraceptives Sales by Manufacturers
  6. 4.2.1 Global Contraceptives Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Contraceptives Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Contraceptives Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Contraceptives Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Contraceptives Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Contraceptives Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Contraceptives Manufacturers, Product Type & Application
  13. 4.7 Global Contraceptives Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Contraceptives Market CR5 and HHI
  16. 4.8.2 2025 Contraceptives Tier 1, Tier 2, and Tier 3
5 Contraceptives Market by Type
  1. 5.1 Global Contraceptives Revenue by Type
  2. 5.1.1 Global Contraceptives Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Contraceptives Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Contraceptives Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Contraceptives Sales by Type
  6. 5.2.1 Global Contraceptives Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Contraceptives Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Contraceptives Sales Market Share by Type (2021-2032)
  9. 5.3 Global Contraceptives Price by Type
6 Contraceptives Market by Application
  1. 6.1 Global Contraceptives Revenue by Application
  2. 6.1.1 Global Contraceptives Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Contraceptives Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Contraceptives Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Contraceptives Sales by Application
  6. 6.2.1 Global Contraceptives Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Contraceptives Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Contraceptives Sales Market Share by Application (2021-2032)
  9. 6.3 Global Contraceptives Price by Application
7 Company Profiles
  1. 7.1 Bayer AG
  2. 7.1.1 Bayer AG Company Information
  3. 7.1.2 Bayer AG Business Overview
  4. 7.1.3 Bayer AG Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bayer AG Contraceptives Product Portfolio
  6. 7.1.5 Bayer AG Recent Developments
  7. 7.2 Pfizer, Inc
  8. 7.2.1 Pfizer, Inc Company Information
  9. 7.2.2 Pfizer, Inc Business Overview
  10. 7.2.3 Pfizer, Inc Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer, Inc Contraceptives Product Portfolio
  12. 7.2.5 Pfizer, Inc Recent Developments
  13. 7.3 Teva Pharmaceutical Industries Ltd
  14. 7.3.1 Teva Pharmaceutical Industries Ltd Company Information
  15. 7.3.2 Teva Pharmaceutical Industries Ltd Business Overview
  16. 7.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio
  18. 7.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
  19. 7.4 Merck & Co., Inc
  20. 7.4.1 Merck & Co., Inc Company Information
  21. 7.4.2 Merck & Co., Inc Business Overview
  22. 7.4.3 Merck & Co., Inc Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck & Co., Inc Contraceptives Product Portfolio
  24. 7.4.5 Merck & Co., Inc Recent Developments
  25. 7.5 Actavis, Inc.
  26. 7.5.1 Actavis, Inc. Company Information
  27. 7.5.2 Actavis, Inc. Business Overview
  28. 7.5.3 Actavis, Inc. Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Actavis, Inc. Contraceptives Product Portfolio
  30. 7.5.5 Actavis, Inc. Recent Developments
  31. 7.6 Johnson & Johnson
  32. 7.6.1 Johnson & Johnson Company Information
  33. 7.6.2 Johnson & Johnson Business Overview
  34. 7.6.3 Johnson & Johnson Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Johnson & Johnson Contraceptives Product Portfolio
  36. 7.6.5 Johnson & Johnson Recent Developments
  37. 7.7 Gedeon Richter
  38. 7.7.1 Gedeon Richter Company Information
  39. 7.7.2 Gedeon Richter Business Overview
  40. 7.7.3 Gedeon Richter Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Gedeon Richter Contraceptives Product Portfolio
  42. 7.7.5 Gedeon Richter Recent Developments
  43. 7.8 Novo Nordisk A/S
  44. 7.8.1 Novo Nordisk A/S Company Information
  45. 7.8.2 Novo Nordisk A/S Business Overview
  46. 7.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Novo Nordisk A/S Contraceptives Product Portfolio
  48. 7.8.5 Novo Nordisk A/S Recent Developments
  49. 7.9 ZiZhu
  50. 7.9.1 ZiZhu Company Information
  51. 7.9.2 ZiZhu Business Overview
  52. 7.9.3 ZiZhu Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 ZiZhu Contraceptives Product Portfolio
  54. 7.9.5 ZiZhu Recent Developments
  55. 7.10 Baijingyu
  56. 7.10.1 Baijingyu Company Information
  57. 7.10.2 Baijingyu Business Overview
  58. 7.10.3 Baijingyu Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Baijingyu Contraceptives Product Portfolio
  60. 7.10.5 Baijingyu Recent Developments
  61. 7.11 Huazhong
  62. 7.11.1 Huazhong Company Information
  63. 7.11.2 Huazhong Business Overview
  64. 7.11.3 Huazhong Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Huazhong Contraceptives Product Portfolio
  66. 7.11.5 Huazhong Recent Developments
  67. 7.12 Sine
  68. 7.12.1 Sine Company Information
  69. 7.12.2 Sine Business Overview
  70. 7.12.3 Sine Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Sine Contraceptives Product Portfolio
  72. 7.12.5 Sine Recent Developments
  73. 7.13 Reckitt
  74. 7.13.1 Reckitt Company Information
  75. 7.13.2 Reckitt Business Overview
  76. 7.13.3 Reckitt Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Reckitt Contraceptives Product Portfolio
  78. 7.13.5 Reckitt Recent Developments
  79. 7.14 AbbVie
  80. 7.14.1 AbbVie Company Information
  81. 7.14.2 AbbVie Business Overview
  82. 7.14.3 AbbVie Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 AbbVie Contraceptives Product Portfolio
  84. 7.14.5 AbbVie Recent Developments
  85. 7.15 Church & Dwight
  86. 7.15.1 Church & Dwight Company Information
  87. 7.15.2 Church & Dwight Business Overview
  88. 7.15.3 Church & Dwight Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Church & Dwight Contraceptives Product Portfolio
  90. 7.15.5 Church & Dwight Recent Developments
  91. 7.16 The Cooper Companies
  92. 7.16.1 The Cooper Companies Company Information
  93. 7.16.2 The Cooper Companies Business Overview
  94. 7.16.3 The Cooper Companies Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 The Cooper Companies Contraceptives Product Portfolio
  96. 7.16.5 The Cooper Companies Recent Developments
  97. 7.17 TherapeuticsMD
  98. 7.17.1 TherapeuticsMD Company Information
  99. 7.17.2 TherapeuticsMD Business Overview
  100. 7.17.3 TherapeuticsMD Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 TherapeuticsMD Contraceptives Product Portfolio
  102. 7.17.5 TherapeuticsMD Recent Developments
  103. 7.18 Afaxys
  104. 7.18.1 Afaxys Company Information
  105. 7.18.2 Afaxys Business Overview
  106. 7.18.3 Afaxys Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Afaxys Contraceptives Product Portfolio
  108. 7.18.5 Afaxys Recent Developments
  109. 7.19 Mithra Pharmaceuticals
  110. 7.19.1 Mithra Pharmaceuticals Company Information
  111. 7.19.2 Mithra Pharmaceuticals Business Overview
  112. 7.19.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Mithra Pharmaceuticals Contraceptives Product Portfolio
  114. 7.19.5 Mithra Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Contraceptives Market Size by Type
  2. 8.1.1 North America Contraceptives Revenue by Type (2021-2032)
  3. 8.1.2 North America Contraceptives Sales by Type (2021-2032)
  4. 8.1.3 North America Contraceptives Price by Type (2021-2032)
  5. 8.2 North America Contraceptives Market Size by End User
  6. 8.2.1 North America Contraceptives Revenue by End User (2021-2032)
  7. 8.2.2 North America Contraceptives Sales by End User (2021-2032)
  8. 8.2.3 North America Contraceptives Price by End User (2021-2032)
  9. 8.3 North America Contraceptives Market Size by Country
  10. 8.3.1 North America Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Contraceptives Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Contraceptives Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Contraceptives Market Size by Type
  2. 9.1.1 Europe Contraceptives Revenue by Type (2021-2032)
  3. 9.1.2 Europe Contraceptives Sales by Type (2021-2032)
  4. 9.1.3 Europe Contraceptives Price by Type (2021-2032)
  5. 9.2 Europe Contraceptives Market Size by End User
  6. 9.2.1 Europe Contraceptives Revenue by End User (2021-2032)
  7. 9.2.2 Europe Contraceptives Sales by End User (2021-2032)
  8. 9.2.3 Europe Contraceptives Price by End User (2021-2032)
  9. 9.3 Europe Contraceptives Market Size by Country
  10. 9.3.1 Europe Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Contraceptives Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Contraceptives Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Contraceptives Market Size by Type
  2. 10.1.1 China Contraceptives Revenue by Type (2021-2032)
  3. 10.1.2 China Contraceptives Sales by Type (2021-2032)
  4. 10.1.3 China Contraceptives Price by Type (2021-2032)
  5. 10.2 China Contraceptives Market Size by End User
  6. 10.2.1 China Contraceptives Revenue by End User (2021-2032)
  7. 10.2.2 China Contraceptives Sales by End User (2021-2032)
  8. 10.2.3 China Contraceptives Price by End User (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Contraceptives Market Size by Type
  2. 11.1.1 Asia Contraceptives Revenue by Type (2021-2032)
  3. 11.1.2 Asia Contraceptives Sales by Type (2021-2032)
  4. 11.1.3 Asia Contraceptives Price by Type (2021-2032)
  5. 11.2 Asia Contraceptives Market Size by End User
  6. 11.2.1 Asia Contraceptives Revenue by End User (2021-2032)
  7. 11.2.2 Asia Contraceptives Sales by End User (2021-2032)
  8. 11.2.3 Asia Contraceptives Price by End User (2021-2032)
  9. 11.3 Asia Contraceptives Market Size by Country
  10. 11.3.1 Asia Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Contraceptives Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Contraceptives Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Contraceptives Market Size by Type
  2. 12.1.1 SAMEA Contraceptives Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Contraceptives Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Contraceptives Price by Type (2021-2032)
  5. 12.2 SAMEA Contraceptives Market Size by End User
  6. 12.2.1 SAMEA Contraceptives Revenue by End User (2021-2032)
  7. 12.2.2 SAMEA Contraceptives Sales by End User (2021-2032)
  8. 12.2.3 SAMEA Contraceptives Price by End User (2021-2032)
  9. 12.3 SAMEA Contraceptives Market Size by Country
  10. 12.3.1 SAMEA Contraceptives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Contraceptives Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Contraceptives Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Contraceptives Value Chain Analysis
  2. 13.1.1 Contraceptives Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Contraceptives Production Mode & Process
  6. 13.2 Contraceptives Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Contraceptives Distributors
  9. 13.2.3 Contraceptives Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst